MeSH tree: C15.378.463
Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma cells begin to multiply, ...
Apr 14, 2026
0
10
Scientists have created a new "molecular map" uncovering how an important human receptor involved in blood clotting and inflammation works—an advance that could help us design better drugs for conditions such as pulmonary ...
Apr 7, 2026
0
4
Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilize the disease and alleviate ...
Mar 31, 2026
0
6
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a cell surface receptor protein called TIE2 as the missing link between two key signaling pathways that drive the growth of ...
Mar 27, 2026
0
2
Dana-Farber Cancer Institute investigators have developed an online, easy-to-use tool that more accurately predicts when a precursor blood condition called smoldering multiple myeloma is likely to turn into active cancer ...
Mar 24, 2026
0
3
For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an elaborate process: Doctors extract a patient's immune cells, ship them to a specialized facility where ...
Mar 18, 2026
0
134
Canadian health officials are investigating the deaths of two people who donated plasma at private clinics in Winnipeg, Manitoba.
Mar 16, 2026
0
6
Vitamin C is one of the most iconic nutrients in popular health culture, often credited with preventing colds, boosting immunity and even fighting serious diseases.
Mar 13, 2026
0
9
People with limited English are significantly more likely to understand the true aim of cancer treatment when given a bilingual consent form, with understanding rising from 35% to 60%, a new study finds. The study, published ...
Mar 13, 2026
0
4
Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact on survival among people living with multiple myeloma, according to new international ...
Mar 2, 2026
0
9
